Fluent Corp. (2WM0)
XFRA 
Summary
2WM0 Chart
Top Marijuana Penny Stocks to Watch in March 2026
The cannabis sector continues attracting investor attention despite years of volatility. Many marijuana stocks experienced large declines during the past two years. However, investors are once again watching the sector for potential recovery. Federal cannabis reform discussions remain a major catalyst for the industry. In addition, possible rescheduling of cannabis has increased speculation about future legalization progress.
Marijuana Stocks to Watch as 2026 Trading Momentum Builds
The U.S. cannabis sector continues adjusting as February 2026 approaches. While volatility remains, investor interest has not disappeared. Instead, attention has shifted toward sustainability and execution. Many cannabis operators now prioritize efficiency over rapid expansion. Higher interest rates forced companies to reassess spending habits. As a result, balance sheet strength has become increasingly important. Revenue quality now matters more than headline growth figures. Companies generating consistent sales stand out more clearly.
Best Marijuana Penny Stocks for January 2026: High-Risk, High-Reward Plays
U.S. marijuana penny stocks can deliver sharp moves in short periods. That volatility creates opportunity, but it also raises risk. Therefore, focusing on operators with real assets and retail exposure matters. Companies with dispensaries, production, and brand recognition often hold attention longer. As January 2026 begins, these three names stand out for different reasons.
Fluent Corp. (2WM0) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Fluent Corp. ever had a stock split?
Fluent Corp. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | David E. Vautrin CEO | XFRA Exchange | CA34380L1022 ISIN |
| US Country | 826 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Cansortium Inc., established in 2018 and based in Tampa, Florida, operates through its subsidiaries to provide medical cannabis in the states of Florida, Pennsylvania, and Texas. The company focuses on the production and sale of medical cannabis products, catering to patients' needs under the Fluent brand name. Alongside its proprietary products, Cansortium Inc. markets various third-party medical cannabis products, expanding its offerings to cater to a broader range of preferences and requirements within the medical cannabis community.
Products and Services
Under the Fluent brand name, Cansortium Inc. offers a diverse array of medical cannabis products designed to meet different consumer preferences and medical requirements:
- Oral Drops: Liquid cannabis extracts designed for oral consumption, offering a discreet and easy dosage method for patients.
- Capsules: Pre-measured, convenient form of cannabis, ideal for those seeking precise dosages without inhalation.
- Topicals: Cannabis-infused creams and balms applied directly to the skin, targeting localized relief without systemic effects.
- Syringes: Pure cannabis oil in syringes for precise dosing, versatile for oral, topical, or inhalation use.
- Dried Flower: Traditional form of cannabis for smoking or vaporizing, catering to users preferring a natural consumption method.
- Pre-rolls: Ready-to-use cannabis cigarettes that remove the hassle of grinding, rolling, and sealing cannabis flowers.
- Cartridges: Cannabis oil cartridges for vaporizers, offering a discreet and portable inhalation option.
- Concentrates: Highly potent cannabis extracts for experienced users, available in various textures and potencies.
- Edibles: Cannabis-infused foods providing a smokeless consumption alternative with delayed but prolonged effects.
In addition to the Fluent-branded products, Cansortium Inc. also provides a selection of third-party branded medical cannabis products, ensuring patients have access to a wide range of therapeutic options.
